We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

45 hedge funds and large institutions have $30.1M invested in Cumberland Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less capital invested

Capital invested by funds: $30.2M → $30.1M (-$109K)

4% less funds holding

Funds holding: 47 → 45 (-2)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
16
Closed
4
Calls
$41K
Puts
–
Net Calls
+$41K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$988K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$550K
3
Norges Bank
Norges Bank
Norway
+$100K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$44.7K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$17.9K

Top Sellers

Rank Fund Capital Flow
1
KIM
Kestrel Investment Management
California
-$959K
2
PCM
Perritt Capital Management
Illinois
-$501K
3
Renaissance Technologies
Renaissance Technologies
New York
-$83.9K
4
BIT
BlackRock Institutional Trust
California
-$67.7K
5
Citadel Advisors
Citadel Advisors
Florida
-$65K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$12M -$1.56K -350 -0%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$3.85M +$550K +123,202 +17%
BIT
3
BlackRock Institutional Trust
California
$2.28M -$67.7K -15,160 -3%
Millennium Management
4
Millennium Management
New York
$2.27M +$988K +221,160 +78%
New York State Common Retirement Fund
5
New York State Common Retirement Fund
New York
$1.38M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.22M +$12.9K +2,900 +1%
GHA
7
GW Henssler & Associates
Georgia
$972K – – –
UCFA
8
United Capital Financial Advisors
Texas
$889K – – –
KIM
9
Kestrel Investment Management
California
$619K -$959K -214,850 -61%
LSV Asset Management
10
LSV Asset Management
Illinois
$450K – – –
BA
11
Bard Associates
Illinois
$402K -$8.48K -1,900 -2%
BCM
12
Bridgeway Capital Management
Texas
$378K – – –
Renaissance Technologies
13
Renaissance Technologies
New York
$346K -$83.9K -18,797 -20%
Morgan Stanley
14
Morgan Stanley
New York
$311K +$11.4K +2,544 +4%
GCP
15
GSA Capital Partners
United Kingdom
$277K -$1.93K -432 -0.7%
Invesco
16
Invesco
Georgia
$262K -$5.8K -1,300 -2%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$242K – – –
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$216K +$17.9K +4,000 +9%
Norges Bank
19
Norges Bank
Norway
$202K +$100K +22,400 +100%
BFA
20
BlackRock Fund Advisors
California
$200K +$5.68K +1,272 +3%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$193K -$353 -79 -0.2%
PP
22
PDT Partners
New York
$144K – – –
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$141K -$7.87K -1,763 -5%
SIM
24
Spark Investment Management
New York
$124K -$14.3K -3,200 -10%
CCM
25
Coldstream Capital Management
Washington
$122K – – –
1
2

CPIX Hedge Fund Activity: Q2 2014 in Review

45 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2014, worth a combined $30.1M — down 0.36% from $30.2M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CPIX and 2 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Millennium Management, adding an estimated $988K. The largest seller was Kestrel Investment Management, cutting an estimated $959K.

  • 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2014, down from 47 in Q1 2014.
  • Funds reported $30.1M of Cumberland Pharmaceuticals stock for Q2 2014, down 0.36% quarter-over-quarter.
  • 2 funds opened new Cumberland Pharmaceuticals positions in Q2 2014 and 4 closed out, a net change of -2 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q2 2014 was Millennium Management, an estimated $988K added.
  • The largest Cumberland Pharmaceuticals seller in Q2 2014 was Kestrel Investment Management, an estimated $959K sold.

Based on aggregated 13F filings for Q2 2014.